These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17363578)

  • 1. 15-deoxy-Delta12,14-prostaglandin J2 inhibits transcriptional activity of estrogen receptor-alpha via covalent modification of DNA-binding domain.
    Kim HJ; Kim JY; Meng Z; Wang LH; Liu F; Conrads TP; Burke TR; Veenstra TD; Farrar WL
    Cancer Res; 2007 Mar; 67(6):2595-602. PubMed ID: 17363578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein thiol modification by 15-deoxy-Delta12,14-prostaglandin J2 addition in mesangial cells: role in the inhibition of pro-inflammatory genes.
    Sánchez-Gómez FJ; Cernuda-Morollón E; Stamatakis K; Pérez-Sala D
    Mol Pharmacol; 2004 Nov; 66(5):1349-58. PubMed ID: 15317873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R; Iñiguez MA; Fresno M
    Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cyclopentenone-type prostaglandin 15-deoxy-delta 12,14-prostaglandin J2 inhibits CD95 ligand gene expression in T lymphocytes: interference with promoter activation via peroxisome proliferator-activated receptor-gamma-independent mechanisms.
    Cippitelli M; Fionda C; Di Bona D; Lupo A; Piccoli M; Frati L; Santoni A
    J Immunol; 2003 May; 170(9):4578-92. PubMed ID: 12707336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of estrogen receptor beta-mediated human telomerase reverse transcriptase gene transcription via the suppression of mitogen-activated protein kinase signaling plays an important role in 15-deoxy-Delta(12,14)-prostaglandin J(2)-induced apoptosis in cancer cells.
    Kondoh K; Tsuji N; Asanuma K; Kobayashi D; Watanabe N
    Exp Cell Res; 2007 Oct; 313(16):3486-96. PubMed ID: 17706193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 15-deoxy-Delta12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors.
    Kim EH; Surh YJ
    Biochem Pharmacol; 2006 Nov; 72(11):1516-28. PubMed ID: 16987499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor gamma in human breast carcinoma: a modulator of estrogenic actions.
    Suzuki T; Hayashi S; Miki Y; Nakamura Y; Moriya T; Sugawara A; Ishida T; Ohuchi N; Sasano H
    Endocr Relat Cancer; 2006 Mar; 13(1):233-50. PubMed ID: 16601291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of trail gene expression by cyclopentenonic prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in T lymphocytes.
    Fionda C; Nappi F; Piccoli M; Frati L; Santoni A; Cippitelli M
    Mol Pharmacol; 2007 Nov; 72(5):1246-57. PubMed ID: 17673570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of c-jun N-terminal kinase activation in 15-deoxy-delta12,14-prostaglandin J2-and prostaglandin A1-induced apoptosis in AGS gastric epithelial cells.
    Liu JD; Lin SY; Ho YS; Pan S; Hung LF; Tsai SH; Lin JK; Liang YC
    Mol Carcinog; 2003 May; 37(1):16-24. PubMed ID: 12720296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 15-deoxy-Delta12,14-prostaglandin J2 inhibits glucocorticoid binding and signaling in macrophages through a peroxisome proliferator-activated receptor gamma-independent process.
    Cheron A; Peltier J; Perez J; Bellocq A; Fouqueray B; Baud L
    J Immunol; 2004 Jun; 172(12):7677-83. PubMed ID: 15187150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
    Farrajota K; Cheng S; Martel-Pelletier J; Afif H; Pelletier JP; Li X; Ranger P; Fahmi H
    Arthritis Rheum; 2005 Jan; 52(1):94-104. PubMed ID: 15641079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of ERalpha signalling pathway by PPARgamma agonists: evidences of PPARgamma-independent events in two hormone-dependent breast cancer cell lines.
    Lecomte J; Flament S; Salamone S; Boisbrun M; Mazerbourg S; Chapleur Y; Grillier-Vuissoz I
    Breast Cancer Res Treat; 2008 Dec; 112(3):437-51. PubMed ID: 18204896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 15-deoxy-Delta12,14-prostaglandin J2 inhibits LPS-stimulated AKT and NF-kappaB activation and suppresses interleukin-6 in osteoblast-like cells MC3T3E-1.
    Jung WK; Park IS; Park SJ; Yea SS; Choi YH; Oh S; Park SG; Choi IW
    Life Sci; 2009 Jul; 85(1-2):46-53. PubMed ID: 19409914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits HIV-1 transactivating protein, Tat, through covalent modification.
    Kalantari P; Narayan V; Henderson AJ; Prabhu KS
    FASEB J; 2009 Aug; 23(8):2366-73. PubMed ID: 19299483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 15-Deoxy-Delta 12,14-prostaglandin J2 inhibition of NF-kappaB-DNA binding through covalent modification of the p50 subunit.
    Cernuda-Morollón E; Pineda-Molina E; Cañada FJ; Pérez-Sala D
    J Biol Chem; 2001 Sep; 276(38):35530-6. PubMed ID: 11466314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 15-Deoxy-delta 12, 14-prostaglandin J2 induces upregulation of multidrug resistance-associated protein 1 via Nrf2 activation in human breast cancer cells.
    Song NY; Kim DH; Kim EH; Na HK; Surh YJ
    Ann N Y Acad Sci; 2009 Aug; 1171():210-6. PubMed ID: 19723058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of peripheral kappa/delta opioid receptors mediates 15-deoxy-(Delta12,14)-prostaglandin J2 induced-antinociception in rat temporomandibular joint.
    Pena-dos-Santos DR; Severino FP; Pereira SA; Rodrigues DB; Cunha FQ; Vieira SM; Napimoga MH; Clemente-Napimoga JT
    Neuroscience; 2009 Nov; 163(4):1211-9. PubMed ID: 19647045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin J2 metabolites inhibit aromatase activity by redox-sensitive mechanisms: potential implications for breast cancer therapy.
    Winnett G; van Hagen D; Schrey M
    Int J Cancer; 2003 Feb; 103(5):600-5. PubMed ID: 12494466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits angiotensin II-induced fibronectin expression via hepatocyte growth factor induction in human peritoneal mesothelial cells.
    Yokoyama Y; Masaki T; Kiribayashi K; Nakashima A; Kokoroishi K; Ogawa T; Kohno N; Yorioka N
    Ther Apher Dial; 2010 Feb; 14(1):43-51. PubMed ID: 20438519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 15-deoxy-Delta12,14-prostaglandin J2 negatively regulates rankl gene expression in activated T lymphocytes: role of NF-kappaB and early growth response transcription factors.
    Fionda C; Nappi F; Piccoli M; Frati L; Santoni A; Cippitelli M
    J Immunol; 2007 Apr; 178(7):4039-50. PubMed ID: 17371958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.